$99.2 Million is the total value of Valliance Asset Management Ltd's 6 reported holdings in Q3 2021. The portfolio turnover from Q2 2021 to Q3 2021 was 100.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
New | SEA LTDnote 0.250% 9/1 | $30,420,000 | – | 30,000,000 | +100.0% | 30.66% | – | |
SE | New | SEA LTDsponsord ads | $23,204,000 | – | 72,800 | +100.0% | 23.39% | – |
New | BILIBILI INCnote 1.250% 6/1 | $18,284,000 | – | 10,200,000 | +100.0% | 18.43% | – | |
SMIHU | SUMMIT HEALTHCRE ACQUISTN COunit 06/03/2026 | $10,050,000 | -0.1% | 1,000,000 | 0.0% | 10.13% | -76.5% | |
Buy | PINDUODUO INCnote 12/0 | $9,300,000 | +77.8% | 10,000,000 | +100.0% | 9.38% | -58.1% | |
HHLAU | HH&L ACQUISITION COunit 99/99/9999 | $7,944,000 | -1.6% | 800,000 | 0.0% | 8.01% | -76.8% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-10-27
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
HH&L ACQUISITION CO | 8 | Q4 2022 | 100.0% |
SUMMIT HEALTHCRE ACQUISTN CO | 7 | Q4 2022 | 55.2% |
PINDUODUO INC | 4 | Q4 2021 | 55.8% |
TAIWAN SEMICONDUCTOR MFG LTD | 3 | Q2 2023 | 63.9% |
YS BIOPHARMA CO LTD | 3 | Q3 2023 | 35.4% |
YS BIOPHARMA CO LTD | 3 | Q3 2023 | 0.6% |
HH&L ACQUISITION CO | 3 | Q3 2023 | 0.1% |
ALIBABA GROUP HLDG LTD | 2 | Q1 2023 | 54.4% |
SEA LTD | 2 | Q3 2021 | 42.3% |
NVIDIA CORPORATION | 2 | Q3 2023 | 23.0% |
View Valliance Asset Management Ltd's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-01-31 |
13F-HR | 2023-10-27 |
13F-HR | 2023-07-26 |
13F-HR | 2023-05-10 |
13F-HR | 2023-02-07 |
13F-HR | 2022-11-09 |
13F-HR | 2022-08-10 |
13F-HR | 2022-04-25 |
13F-HR | 2022-01-28 |
13F-HR | 2021-10-27 |
View Valliance Asset Management Ltd's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.